Cellectar Biosciences, Inc. Investments and Other Noncurrent Assets
Cellectar Biosciences, Inc. (CLRB) had Investments and Other Noncurrent Assets of $63.22 thousand as of 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InvestmentsAndOtherNoncurrentAssets · last filed 2023-05-04
- 2023-03-31: Investments and Other Noncurrent Assets $63.22K.
- 2022-12-31: Investments and Other Noncurrent Assets $75.00K.
- 2022-09-30: Investments and Other Noncurrent Assets $81.21K.
- 2022-06-30: Investments and Other Noncurrent Assets $81.21K.
| Period end | Investments and Other Noncurrent Assets |
|---|---|
| 2023-03-31 | $63.22K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $75.00K 10-Q · filed 2023-05-04 |
| 2022-09-30 | $81.21K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $81.21K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $81.21K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $81.21K 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |